Summary
A study was made of intrathecal infusion as a route for administration of drugs for the CNS. We recognize the presence of blood brain and CSF brain barriers. CDP-choline was used as the brain activator, and the effect of the intrathecally infused drug was investigated clinically. Fifteen patients with disturbances of consciousness due to primary cerebral lesions received a total of 39 intrathecal infusions of CDP-choline, and were examined neurologically and electroencephalographically before and after treatment.
Similar content being viewed by others
References
Hayashi, O.et al., Biochemistry of brain injury and brain edema. Nisshin Igaku48 (1961), 519–539.
Hockaday, J. M.et al., Electroencephalographic changes in acute cerebral anoxia from cardiac or respiratory arrest. Electroenceph. clin. Neurophysiol.18 (1965), 575–586.
Ijichi, H.et al., Basic study of clinical application of CDP-choline. Med. Treatm.5 (1972), 67–74.
Ishii, S.et al., Application of nucleic acid derivatives for coma due to head injury. J. Jap. Surg. Soc.63 (1962), 1013–1014.
Ishikawa, S.et al., Clinical application of CDP-choline and its theoretical background. J. Hiroshima Med. Ass.26 (1973), 679–683.
Kondo, Y., Application of nucleic acid derivatives for head injury with particular reference to the therapeutic effect of cytidine nucleotide. Arch. J. Chir.32 (1963), 489–505.
Miyake, H.et al., Treatment with intermediate substances in cerebral metabolic cycles for head injury. Part. 1. Application of CDP-choline. Brain Nerve16 (1964), 873–878.
Ogashiwa, M.et al., Studies on intrathecal pharmacotherapy; CDP-choline. Brain Nerve26 (1974), 1181–1187.
Yonekawa, Y.et al., In vivo distribution and metabolism of CDP-choline. Brain Nerve22 (1970), 871–875.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ogashiwa, M., Takeuchi, K. Intrathecal pharmaeotherapy in coma. Acta neurochir 34, 37–44 (1976). https://doi.org/10.1007/BF01405861
Issue Date:
DOI: https://doi.org/10.1007/BF01405861